Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
News: Latest News
Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors

Bloq : Partners With Deloitte to Build Blockchain Solutions

05/03/2016 | 06:00am EDT

CHICAGO, IL--(Marketwired - May 3, 2016) - Bloq (bloq.com) announced that is working with Deloitte, which works with each of the top 30 banks across its member firms globally, to build blockchain software solutions for leading companies worldwide. Through this partnership, Bloq will help deliver enterprise-grade blockchain solutions based on the core values of open source, security and reliability.

"Deloitte's market leadership in financial services coupled with Bloq's expertise in blockchain technology, creates a very powerful combination in the industry," said Matthew Roszak, co-founder and chairman of Bloq. "Every CTO on the planet is in the process of developing their blockchain strategy, and this partnership will help further enable these discussions with the guidance and expertise they need," said Roszak.

This is part of Deloitte's initiative to develop blockchain-related prototypes addressing digital identity, digital banking, cross-border payments, loyalty and rewards, as well as products for the investment management and insurance sectors. Bloq's software and services can help provide new technological features and capabilities to Deloitte's client base of global financial institutions.

"Blockchain is proving to be a major disruptive force in financial services," said Eric Piscini, principal with Deloitte Consulting LLP and the global financial services blockchain leader. "We continue to focus on helping our clients make blockchain a reality for their business. Together, we are harvesting the benefits of blockchain technologies -- developing new revenue models, improving cost efficiencies and creating innovative solutions across the globe."

Bloq's software and expertise will help enable Deloitte to work with clients to rapidly build and test ideas, leveraging the latest solutions and integrating them into complex client environments.

About Bloq
Bloq delivers enterprise-grade blockchain solutions to leading companies worldwide. Bloq helps its clients and partners build key layers of infrastructure for blockchain-enabled applications with world-class developer expertise and full 24/7 customer support. For more information, please visit: bloq.com.

About Deloitte
Deloitte provides industry-leading audit, consulting, tax and advisory services to many of the world's most admired brands, including 80 percent of the Fortune 500. Our people work across more than 20 industry sectors to deliver measurable and lasting results that help reinforce public trust in our capital markets, inspire clients to make their most challenging business decisions with confidence, and help lead the way toward a stronger economy and a healthy society.


© Marketwired 2016
Latest news "Companies"
09:35a Celltrion's monoclonal antibody treatment for COVID-19, regdanvimab (CT-P59) becomes the first authorized COVID-19 treatment approved from the Korean Ministry of Food and Drug Safety (MFDS)
BU
09:34aDEADLINE ALERT : Kessler Topaz Meltzer & Check, LLP Announces Deadline in Cassava Sciences, Inc. Securities Fraud Class Action Lawsuit
GL
09:32a“Turkey's export capacity is its trump card to feature among the world's top 10 economies”
PU
09:32aJET2 : Bookings surge update - Saturday 18th September »
PU
09:24aAustralia made 'huge mistake' in cancelling submarine deal, says French envoy
RE
09:12aASTRAZENECA : Enhertu reduced the risk of disease progression or death by 72% vs. trastuzumab emtansine (T-DM1) in patients with HER2-positive metastatic breast cancer
PU
09:07aSHANGHAI ELECTRIC : Ranks 51st on ENR's 2021 Top 250 International Contractors List
AQ
09:07aDAIICHI SANKYO : ENHERTU® Reduced the Risk of Disease Progression or Death by 72% Versus Trastuzumab Emtansine (T-DM1) in Patients with HER2 Positive Metastatic Breast Cancer
BU
09:07aASTRAZENECA : ENHERTU® (fam-trastuzumab deruxtecan-nxki) reduced the risk of disease progression or death by 72% vs. trastuzumab emtansine (T-DM1) in patients with HER2-positive metastatic breast cancer
BU
09:06aMERCK : KEYTRUDA® (pembrolizumab) Plus Chemotherapy With or Without Bevacizumab Reduced Risk of Death by One-Third Versus Chemotherapy With or Without Bevacizumab as First-Line Treatment for Persistent, Recurrent or Metastatic Cervical Cancer
BU
Latest news "Companies"